NJ Prescription Monitoring Program (NJPMP)

New Jersey Division of Consumer Affairs

Information for Pharmacies; NJPMP Reporting Requirements

Please be advised that beginning March 1, 2014, pharmacies will be required to report information to the NJPMP on a weekly basis using the ASAP 4.2 format. However, in order to help facilitate any software conversion that may be necessary, the NJPMP will continue to accept submissions using the ASAP 4.0, 4.1/2009 format until September 1, 2014

Pursuant to N.J.S.A. 45:1-45 et. seq., pharmacies that dispense Schedule II-V Controlled Dangerous Substances (CDS) in New Jersey, or into New Jersey, are required to submit data on all transactions for such drugs to the New Jersey Prescription Monitoring Program (NJPMP).

The New Jersey Division of Consumer Affairs, using its discretion under the NJPMP statute, added the requirement that pharmacies provide data on all transactions related to Human Growth Hormone (HGH).

Pharmacies must upload the required CDS and HGH prescription data via www.NJRxReport.com.

Pharmacies must submit this data at least twice per month. They are encouraged to report prior to the deadlines, to allow for the correction of any rejected submissions. Pharmacies may report more frequently if they prefer to do so.

For technical assistance with the NJPMP database, contact Optimum Technology's help desk at 1-866-683-2476 or njrxreport@otech.com.

Important Links: